subject: UMLS:C3526553


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine

object_name: Apnea in newborn

tested_intervention: unsure


subject: UMLS:C3526553

object_name: Premature infant


subject: UMLS:C3526553

object_name: Premature birth


subject: CHEBI:143719

subject_name: H. influenzae type B capsular polysaccharide

object_name: Apnea


subject: CHEBI:143719

object_name: Apnea, CTCAE


subject: CHEBI:143719


subject: CHEBI:143719


subject: CHEBI:143719


subject: MESH:D011054

subject_name: Poliovirus Vaccine, Inactivated


subject: MESH:D011054


subject: MESH:D011054


subject: MESH:D011054


subject: MESH:D011054


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: spinal cord injury

tested_intervention: yes


subject: UMLS:C1137867

subject_name: BioXtra

object_name: Xerostomia caused by ionizing radiation


subject: PUBCHEM.COMPOUND:13208114

subject_name: MILNACIPRAN HYDROCHLORIDE

object_name: fibromyalgia


subject: CHEBI:31687

subject_name: Idebenone

object_name: MELAS syndrome


subject: CHEBI:44915

subject_name: Propofol

object_name: colon cancer


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Burn injury


subject: CHEBI:90943

subject_name: Osimertinib

object_name: non-small cell squamous lung carcinoma


subject: UNII:CVX52RV2DC

subject_name: TELISOTUZUMAB ADIZUTECAN


subject: UMLS:C4085974

object_name: pancreatic neoplasm


subject: UMLS:C4085974

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4085974

object_name: malignant pancreatic neoplasm


subject: GTOPDB:9311

subject_name: urelumab


subject: GTOPDB:9311


subject: GTOPDB:9311


subject: CHEMBL.COMPOUND:CHEMBL1743085

subject_name: URELUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: UNII:G786V328X6

subject_name: Zatolmilast

object_name: kidney failure


subject: UNII:3I798OGQ8B

subject_name: Fluorofuranylnorprogesterone F-18

object_name: invasive breast carcinoma


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: obstructive sleep apnea syndrome


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:44915

object_name: age


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Locally Advanced Rectal Adenocarcinoma


subject: UNII:9T56TV18X7

object_name: acute myeloid leukemia by FAB classification


subject: UNII:9T56TV18X7

object_name: acute myeloid leukemia


subject: UNII:9T56TV18X7

object_name: Refractory acute myeloid leukemia


subject: UNII:9T56TV18X7

object_name: Relapsing acute myeloid leukemia


subject: CHEBI:104020

object_name: melanoma


subject: UNII:490D9F069T

subject_name: Lanthanum carbonate tetrahydrate

object_name: end stage renal failure


subject: UNII:0M78EU4V9H

subject_name: Lanthanum carbonate


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: asthma


subject: CHEBI:83766

subject_name: Olaparib

object_name: Malignant melanoma of skin of breast


subject: MESH:D005782

subject_name: Gels

object_name: HIV infection


subject: UMLS:C0939677

subject_name: Angiomax

object_name: thrombocytopenia


subject: UMLS:C0939677

object_name: heart disorder


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN


subject: CHEMBL.COMPOUND:CHEMBL5314348


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: UMLS:C1314413


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:59173


subject: CHEBI:50249

subject_name: anticoagulant

object_name: Blood Clot


subject: CHEBI:50249

object_name: thrombosis


subject: CHEBI:50249

object_name: Thrombosis of blood vessel


subject: CHEBI:50249


subject: CHEBI:50249


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C3536711

subject_name: Anti-coagulant [EPC]


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UNII:820NH671E6

subject_name: Prexasertib

object_name: ovarian cancer


subject: UNII:820NH671E6

object_name: ovarian neoplasm


subject: UNII:820NH671E6

object_name: ovarian carcinoma


subject: GTOPDB:8928

subject_name: pamrevlumab

object_name: Pancreatic cancer non-resectable


subject: CHEMBL.COMPOUND:CHEMBL2109377

subject_name: PAMREVLUMAB


subject: UMLS:C2985186


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: Urinary Urgency


subject: CHEBI:33379

subject_name: erbium


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: PR:000007204

subject_name: estrogen receptor


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Osteopenia/osteoporosis


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:132830

subject_name: delta-elemene

object_name: esophageal adenocarcinoma


subject: CHEBI:132830

object_name: lung adenocarcinoma


subject: CHEBI:132830

object_name: cervical adenocarcinoma


subject: CHEBI:132830

object_name: adenocarcinoma


subject: CHEBI:132830

object_name: bile duct adenocarcinoma


subject: CHEBI:132830

object_name: gastric adenocarcinoma


subject: CHEBI:132830

object_name: carcinoma


subject: PUBCHEM.COMPOUND:10583

subject_name: (-)-cis-beta-Elemene


subject: PUBCHEM.COMPOUND:10583


subject: PUBCHEM.COMPOUND:10583


subject: PUBCHEM.COMPOUND:10583


subject: PUBCHEM.COMPOUND:10583


subject: PUBCHEM.COMPOUND:10583


subject: PUBCHEM.COMPOUND:10583


subject: UMLS:C4548011

object_name: Clostridium difficile colitis


subject: UMLS:C4548011

object_name: clostridium difficile infection


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: Android obesity


subject: CHEBI:5778

object_name: Abdominal obesity


subject: CHEBI:7009

subject_name: Moxonidine

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:7009

object_name: metabolic syndrome X


subject: CHEBI:7009


subject: CHEBI:7009


subject: CHEBI:175901

object_name: small intestine cancer


subject: CHEBI:175901

object_name: small intestine carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Transitory tachypnea of newborn


subject: GTOPDB:7394

subject_name: gevokizumab

object_name: pyoderma gangrenosum


subject: CHEMBL.COMPOUND:CHEMBL1743026

subject_name: GEVOKIZUMAB


subject: UMLS:C3179523


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Small cell lung cancer extensive stage


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: portal vein thrombosis


subject: UMLS:C4086713

object_name: Portal Vein Thrombosis, CTCAE


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: prostate carcinoma


subject: CHEBI:4466

object_name: prostate cancer


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UMLS:C1446932

subject_name: Urtica dioica antigen

object_name: type 2 diabetes mellitus


subject: UMLS:C1618310

subject_name: stinging nettle extract


subject: PUBCHEM.COMPOUND:16683012

subject_name: Sodium stibogluconate

object_name: Kala-Azar


subject: PUBCHEM.COMPOUND:16683013

subject_name: Stibogluconate


subject: CHEBI:28148


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: Parkinson disease


subject: UMLS:C4330908

object_name: Refractory acute myeloid leukemia


subject: UMLS:C4330908

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:7521

subject_name: nereistoxin

object_name: opiate dependence


subject: UMLS:C0285526

subject_name: N-telopeptide


subject: PR:000031077

subject_name: COMM domain-containing protein 3


subject: UNII:897NVD4A52

subject_name: p-Chloroamphetamine

object_name: no feeling or sensation of skin


subject: UNII:897NVD4A52

object_name: Sensory Loss


subject: UNII:897NVD4A52

object_name: knee pain chronic


subject: UNII:897NVD4A52

object_name: Arthropathy of knee joint


subject: UNII:897NVD4A52

object_name: osteoarthritis, knee


subject: UNII:897NVD4A52

object_name: rheumatoid arthritis


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:16010


subject: CHEBI:16010


subject: CHEBI:16010


subject: CHEBI:16010


subject: CHEBI:16010


subject: CHEBI:16010


subject: UMLS:C0034330

subject_name: Pidolic acid


subject: UMLS:C0034330


subject: UMLS:C0034330


subject: UMLS:C0034330


subject: UMLS:C0034330


subject: UMLS:C0034330


subject: CHEBI:173763

subject_name: Thermophillin

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:173763

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:173763

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: PUBCHEM.COMPOUND:23597337


subject: PUBCHEM.COMPOUND:23597337


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:4659


subject: CHEBI:4659


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PR:000012938

subject_name: pinin

object_name: premenstrual tension


subject: PR:000012938

object_name: polydactyly-myopia syndrome


subject: PR:000012938

object_name: acne


subject: UMLS:C1696294

subject_name: Yaz


subject: UMLS:C1696294


subject: MESH:C579023

subject_name: AndoSan

object_name: Crohn disease


subject: MESH:C579023

object_name: ulcerative colitis


subject: MESH:C579023

object_name: inflammatory bowel disease 1


subject: CHEBI:4208

subject_name: D-mannopyranose

object_name: multiple sclerosis


subject: UMLS:C5907971

subject_name: Anti-HER3 Antibody-drug Conjugate SHR-A2009

object_name: carcinoma of esophagus


subject: UMLS:C5907971

object_name: esophageal cancer


subject: UMLS:C5907971

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5907971

object_name: neoplasm of esophagus


subject: CHEBI:41423

subject_name: Celecoxib

object_name: hypertension


subject: CHEBI:41423

object_name: Hypertension, CTCAE


subject: UMLS:C1320098

subject_name: Risperdal Consta

object_name: bipolar disorder


subject: PR:000015454

subject_name: sperm-associated antigen 11B

object_name: postmenopausal osteoporosis


subject: PR:000015454

object_name: osteoporosis


subject: PR:000022039

subject_name: dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex


subject: PR:000022039


subject: PR:000015453

subject_name: sperm-associated antigen 11A


subject: PR:000015453


subject: UMLS:C4058555

subject_name: Spiriva Respimat

object_name: chronic obstructive pulmonary disease


subject: UMLS:C4308025

subject_name: AAA 617

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C4308025

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C4308025

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C4308025

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C4308025

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UMLS:C4308025

object_name: Castration Levels of Testosterone


subject: UMLS:C4308025

object_name: prostate adenocarcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: cardiotoxicity


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:93775

subject_name: Amethopterin

object_name: malignant soft tissue neoplasm


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: PUBCHEM.COMPOUND:3417

object_name: Infection


subject: PUBCHEM.COMPOUND:3417

object_name: infectious disease


subject: PUBCHEM.COMPOUND:3417

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:3417

object_name: complication


subject: PUBCHEM.COMPOUND:3417

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:3417

object_name: prostate cancer


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:28915

subject_name: Fosfomycin


subject: CHEBI:28915


subject: CHEBI:28915


subject: CHEBI:28915


subject: CHEBI:28915


subject: CHEBI:28915


subject: CHEMBL.COMPOUND:CHEMBL1650818

subject_name: pivmecillinam


subject: CHEMBL.COMPOUND:CHEMBL1650818


subject: CHEMBL.COMPOUND:CHEMBL1650818


subject: CHEMBL.COMPOUND:CHEMBL1650818


subject: CHEMBL.COMPOUND:CHEMBL1650818


subject: CHEMBL.COMPOUND:CHEMBL1650818


subject: CHEBI:2677

subject_name: Augmentin


subject: CHEBI:2677


subject: CHEBI:2677


subject: CHEBI:2677


subject: CHEBI:2677


subject: CHEBI:2677


subject: RXCUI:151392


subject: RXCUI:151392


subject: RXCUI:151392


subject: RXCUI:151392


subject: RXCUI:151392


subject: RXCUI:151392


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:9332


subject: UMLS:C0304475

subject_name: Potassium supplement

object_name: cardiovascular disorder


subject: UMLS:C0304475

object_name: aneurysm


subject: UMLS:C0304475

object_name: heart disorder


subject: UMLS:C0304475

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0304475

object_name: obesity


subject: UMLS:C0304475

object_name: Obesity, CTCAE


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:26216

subject_name: potassium atom


subject: CHEBI:26216


subject: CHEBI:26216


subject: CHEBI:26216


subject: CHEBI:26216


subject: CHEBI:26216


subject: UMLS:C3714637

subject_name: Potassium Drug Class


subject: UMLS:C3714637


subject: UMLS:C3714637


subject: UMLS:C3714637


subject: UMLS:C3714637


subject: UMLS:C3714637


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: brain neoplasm


subject: CHEBI:6067

object_name: central nervous system neoplasm


subject: CHEBI:6067

object_name: central nervous system cancer


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Post-vasectomy pain


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: Chronic central serous chorioretinopathy


subject: UMLS:C2607549

object_name: Blood Clot


subject: UMLS:C2607549

object_name: thrombosis


subject: UMLS:C2607549

object_name: Thrombosis of blood vessel


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: UMLS:C4505505

object_name: Drug Interactions


subject: UMLS:C4505505

object_name: Adverse drug interaction


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: lymphedema


subject: UMLS:C0279328

object_name: Lymphedema, CTCAE


subject: UMLS:C0279328

object_name: Radiation Fibrosis


subject: UMLS:C0279328

object_name: radiation pneumonitis


subject: UMLS:C0279328

object_name: Childhood Breast Carcinoma


subject: UMLS:C0279328

object_name: breast carcinoma


subject: UMLS:C0279328

object_name: breast cancer


subject: UMLS:C0279328


subject: CHEBI:6121

subject_name: Ketamine

object_name: Generalized convulsive status epilepticus


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Crohn disease


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Advanced Hepatocellular Carcinoma


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: DRUGBANK:DB18143

subject_name: MTL-CEBPA


subject: GTOPDB:4934

subject_name: G-CSF

object_name: neuromyelitis optica


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:17905

subject_name: Coenzyme M


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: CHEBI:73224

subject_name: allyl isothiocyanate

object_name: Allergy


subject: CHEBI:73224

object_name: History of allergies


subject: CHEBI:73224

object_name: respiratory system disorder


subject: PR:000015174

subject_name: sodium-coupled monocarboxylate transporter 1


subject: PR:000015174


subject: PR:000015174


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: B-cell lymphoma refractory


subject: MESH:C520255

object_name: B-cell lymphoma recurrent


subject: MESH:C520255

object_name: Refractory Aggressive Non-Hodgkin Lymphoma


subject: MESH:C520255

object_name: Recurrent Aggressive Adult Non-Hodgkin Lymphoma


subject: MESH:C520255

object_name: Recurrent Aggressive Non-Hodgkin Lymphoma


subject: MESH:C520255

object_name: B-cell small lymphocytic lymphoma refractory


subject: MESH:C520255

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Chemotherapy-Induced Thrombocytopenia


subject: CHEBI:60775

subject_name: Verteporfin

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:60775

object_name: Embolism, Tumor


subject: CHEBI:60775

object_name: Neoplasm Metastasis


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEBI:36939

subject_name: Fluorine F-18

object_name: Childhood Malignant Solid Neoplasm


subject: CHEBI:36939

object_name: Malignant Solid Neoplasm


subject: CHEBI:36939

object_name: neoplasm


subject: UMLS:C4733686

object_name: urothelial carcinoma


subject: UMLS:C4733686

object_name: transitional cell carcinoma


subject: CHEBI:77388

subject_name: tricaprin

object_name: Androgen excess


subject: UMLS:C0729218

object_name: focal segmental glomerulosclerosis


subject: UMLS:C0729218

object_name: Focal Segmental Glomerulosclerosis, Not Otherwise Specified


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UNII:FM5526K07A

subject_name: ZINC ACETATE

object_name: Wilson disease


subject: CHEBI:5134

subject_name: Fluticasone

object_name: croup


subject: CHEBI:5134

object_name: Subglottic laryngitis


subject: UMLS:C0687706

subject_name: Digibind

object_name: bipolar disorder


subject: UMLS:C0021031

subject_name: Fab Immunoglobulins


subject: CHEBI:38940

subject_name: Sunitinib

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:38940

object_name: ISS Stage I Plasma Cell Myeloma


subject: CHEBI:38940

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:38940

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:38940

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:38940

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Harmful pattern of substance use


subject: CHEBI:8707

object_name: substance abuse


subject: CHEBI:8707

object_name: Psychotic disorder due to a general medical condition


subject: CHEBI:6121

subject_name: Ketamine

object_name: laceration of skin (physical finding)


subject: CHEBI:6121

object_name: Skin laceration


subject: UNII:HAX0H28B6W

subject_name: ORVEPITANT MALEATE

object_name: interstitial lung disease 1


subject: UNII:HAX0H28B6W

object_name: interstitial lung disease 2


subject: UNII:HAX0H28B6W

object_name: Cough


subject: UNII:HAX0H28B6W

object_name: Cough, CTCAE


subject: UMLS:C2983800

subject_name: Orvepitant Maleate


subject: UMLS:C2983800


subject: UMLS:C2983800


subject: UMLS:C2983800


subject: CHEBI:240107

subject_name: Bromfenac

object_name: exudative vitreoretinopathy


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Decompensated cirrhosis of liver


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: Hyperdynamic septic shock


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Fused vertebrae


subject: CHEBI:64356

subject_name: Pregabalin


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Myelodysplasia


subject: UMLS:C0919079

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0919079

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0919079

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:58270

subject_name: N-acetyl-L-leucinate

object_name: spinocerebellar ataxia type 6


subject: CHEBI:58270

object_name: migraine, familial hemiplegic, 1


subject: CHEBI:58270

object_name: episodic ataxia type 2


subject: CHEBI:17786

subject_name: L-Acetylleucine


subject: CHEBI:17786


subject: CHEBI:17786


subject: UMLS:C4547971


subject: UMLS:C4547971


subject: UMLS:C4547971


subject: CHEBI:50730

subject_name: Montelukast

object_name: acne


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: colorectal cancer


subject: CHEBI:46245

object_name: colorectal carcinoma


subject: CHEBI:46245

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3852659

subject_name: Teysuno

object_name: Stomach cancer


subject: UMLS:C3852659

object_name: gastric cancer


subject: UNII:UKI9MLD5OI

subject_name: DOM

object_name: lung cancer


subject: UNII:UKI9MLD5OI

object_name: lung neoplasm


subject: UNII:UKI9MLD5OI

object_name: lung carcinoma


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant


subject: UNII:W0ZE0NT8IF


subject: UNII:W0ZE0NT8IF


subject: UNII:TC549UFL8P

object_name: long COVID-19


subject: UMLS:C1831848


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: cervical cancer


subject: UNII:QEN1X95CIX

object_name: cervical carcinoma


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:231683

subject_name: Anakinra

object_name: Premature infant


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:16349

subject_name: Citrulline

object_name: peripheral vascular disease


subject: CHEBI:16349

object_name: peripheral arterial disease


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: Critical Illness


subject: PR:000009978

subject_name: lactotransferrin


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Sepsis


subject: UNII:C8ADC441ME

object_name: Sepsis, CTCAE


subject: GTOPDB:8415

subject_name: tanezumab

object_name: interstitial cystitis


subject: UNII:EQL0E9GCX1


subject: CHEBI:4445

subject_name: Desflurane

object_name: Postoperative delirium


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: liver cirrhosis


subject: CHEBI:64103

subject_name: sodium butyrate

object_name: schizophrenia


subject: CHEBI:64103

object_name: Cognitive impairment


subject: UMLS:C0142812

subject_name: Sodium Butyrate


subject: UMLS:C0142812


subject: CHEBI:30772

subject_name: Butyric Acid


subject: CHEBI:30772


subject: UMLS:C0445115

subject_name: Normal saline

object_name: myofascial pain syndrome


subject: UMLS:C0445115

object_name: fibromyalgia


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: omphalitis


subject: UMLS:C0556607

subject_name: Methylated spirit


subject: UMLS:C0556607

object_name: neonatal sepsis


subject: UMLS:C0556607

object_name: Bacterial sepsis of newborn


subject: UMLS:C5556349

subject_name: Bcl-2 Inhibitor ABBV-623

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5556349

object_name: B-cell neoplasm


subject: UMLS:C5556350

subject_name: BTK Inhibitor ABBV-992


subject: UMLS:C5556350


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Complication of transplanted liver


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Hepatocellular Carcinoma


subject: UNII:DPT0O3T46P


subject: CHEBI:133021

subject_name: Venetoclax

object_name: Refractory Leukemia


subject: CHEBI:133021

object_name: Leukaemia recurrent


subject: UMLS:C5417836

object_name: autoimmune thrombocytopenia


subject: UMLS:C5417836

object_name: thrombocytopenia due to immune destruction


subject: UMLS:C5417836

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Neuromyelitis optica spectrum disorder relapse


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Cross Infection


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C3896806


subject: UMLS:C2826358


subject: UMLS:C2826358

object_name: pancreatic neoplasm


subject: UMLS:C2826358

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2826358

object_name: malignant pancreatic neoplasm


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: head and neck squamous cell carcinoma


subject: CHEBI:229225

subject_name: Bexagliflozin

object_name: diabetes mellitus


subject: UMLS:C2347423

subject_name: OncoGel

object_name: brain cancer


subject: UMLS:C2347423

object_name: brain neoplasm


subject: UMLS:C2347423

object_name: glioblastoma


subject: UMLS:C2347423

object_name: Brain Stem Glioblastoma


subject: UMLS:C2347423

object_name: glioma susceptibility 1


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:4O75889WF4

object_name: acute myeloid leukemia by FAB classification


subject: UNII:4O75889WF4

object_name: acute myeloid leukemia


subject: CHEBI:31401

subject_name: Cilostazol

object_name: rheumatoid arthritis


subject: CHEBI:135962

subject_name: Dapoxetine

object_name: sexual disorder


subject: PUBCHEM.COMPOUND:6093437


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: Systemic inflammatory response


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: CHEBI:134677

subject_name: Crisaborole

object_name: seborrheic dermatitis


subject: MESH:D013488

subject_name: Suppositories

object_name: classic familial adenomatous polyposis


subject: MESH:D013488

object_name: Adenomatous colonic polyposis


subject: UMLS:C1883043

subject_name: Slurry


subject: UMLS:C1883043


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Abortion late


subject: CHEBI:150712

object_name: Asherman syndrome


subject: CHEBI:8887

subject_name: Rofecoxib

object_name: Duodenal polyposis


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Albumin Level Finding


subject: CHEBI:26710

object_name: Risk Scores


subject: CHEBI:125482

subject_name: Nitroaspirin

object_name: intermittent vascular claudication


subject: UMLS:C0950966


subject: CHEBI:134677

object_name: alopecia areata


subject: CHEBI:134677

object_name: alopecia


subject: CHEBI:49140

object_name: chronic pain (diagnosis)


subject: CHEBI:49140

object_name: Chronic pain


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: UNII:B321AL142J

subject_name: molgramostim

object_name: Malignant ascites


subject: UMLS:C0218633


subject: GTOPDB:13796

subject_name: serplulimab


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: UNII:RUU8G67GQM

subject_name: Escin

object_name: Facial edema


subject: UNII:RUU8G67GQM

object_name: Facial swelling (finding)


subject: UNII:RUU8G67GQM

object_name: Post-Operative Pain


subject: UNII:RUU8G67GQM

object_name: Trismus


subject: UNII:RUU8G67GQM

object_name: Trismus, CTCAE


subject: PUBCHEM.COMPOUND:4555259

subject_name: Aescin


subject: PUBCHEM.COMPOUND:4555259


subject: PUBCHEM.COMPOUND:4555259


subject: PUBCHEM.COMPOUND:4555259


subject: PUBCHEM.COMPOUND:4555259


subject: CHEBI:26605

subject_name: saponin


subject: CHEBI:26605


subject: CHEBI:26605


subject: CHEBI:26605


subject: CHEBI:26605


subject: CHEBI:2500

subject_name: beta-Escin


subject: CHEBI:2500


subject: CHEBI:2500


subject: CHEBI:2500


subject: CHEBI:2500


subject: CHEBI:27306

subject_name: vitamin B6

object_name: Childhood Breast Carcinoma


subject: CHEBI:27306

object_name: breast carcinoma


subject: CHEBI:27306

object_name: breast cancer


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Effects of chemotherapy


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form

object_name: cholecystitis


subject: UNII:C4V974V932

object_name: Cholecystitis, CTCAE 3.0


subject: UNII:C4V974V932

object_name: Cholecystitis, CTCAE 5.0


subject: UNII:Z4K58C6RT2

object_name: AIDS


subject: UNII:EXL0L74IKU


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg

object_name: Mesothelioma


subject: UMLS:C5434105

object_name: mesothelial neoplasm


subject: UMLS:C5434105

object_name: malignant mesothelioma


subject: UMLS:C5434105

object_name: pleural mesothelioma


subject: UMLS:C5434105

object_name: malignant pleural mesothelioma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: PUBCHEM.COMPOUND:54580717

subject_name: KARENITECIN

object_name: lung cancer


subject: PUBCHEM.COMPOUND:54580717

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:54580717

object_name: lung carcinoma


subject: CHEBI:177492

subject_name: Cositecan


subject: CHEBI:177492


subject: CHEBI:177492


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Childhood Trauma


subject: CHEBI:60799

subject_name: Esketamine

object_name: Consciousness Disorders


subject: CHEBI:231683

subject_name: Anakinra

object_name: mucopolysaccharidosis type 3


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:42797

subject_name: Gabapentin

object_name: liver cirrhosis


subject: UNII:B5TAN0L720

subject_name: Picoplatin

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3544907

subject_name: PICOPLATIN


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Statin-induced myopathy


subject: UNII:YB18NF020M

subject_name: Satralizumab

object_name: euthyroid Graves orbitopathy


subject: UNII:YB18NF020M

object_name: endocrine exophthalmos


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: triple-negative breast carcinoma


subject: UNII:CWG62Q1VTB

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:CWG62Q1VTB

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:CWG62Q1VTB

object_name: malignant neoplasm of breast stage IV


subject: UNII:CWG62Q1VTB

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: Cognitive impairment


subject: CHEBI:44915

subject_name: Propofol

object_name: Subfertility


subject: CHEBI:9150

subject_name: Simvastatin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:9150

object_name: obesity


subject: CHEBI:9150

object_name: Obesity, CTCAE


subject: CHEBI:135738

subject_name: Clevidipine

object_name: Aortic dissection


subject: CHEBI:135738

object_name: aortic aneurysm


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: urothelial carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: transitional cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: myeloproliferative neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: bone marrow neoplasm


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Sun-induced wrinkles


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C5237722

subject_name: RSK1-4 Inhibitor PMD-026

object_name: Carcinoma breast stage IV


subject: CHEBI:6121

subject_name: Ketamine

object_name: Aggressive behavior


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Oxidative Damage


subject: CHEBI:16480

object_name: Reperfusion Injury


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: colorectal neoplasm


subject: UMLS:C1579319

subject_name: pneumococcal conjugate vaccine

object_name: pneumonia


subject: UMLS:C1579319

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C1579319

object_name: meningitis


subject: UMLS:C1579319

object_name: Meningitis, CTCAE


subject: MESH:C586648

subject_name: 10-valent pneumococcal conjugate vaccine


subject: MESH:C586648


subject: MESH:C586648


subject: MESH:C586648


subject: GTOPDB:13450

subject_name: briquilimab

object_name: immunodeficiency disease


subject: UNII:QWX84D0DRC

subject_name: BRIQUILIMAB


subject: UMLS:C5418059

subject_name: AMG 191


subject: CHEBI:16480

object_name: pulmonary embolism


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: rectal carcinoma


subject: UMLS:C5669600

object_name: rectal cancer


subject: UMLS:C5669600

object_name: Childhood Rectal Carcinoma


subject: UNII:9TMU325RK3

subject_name: Lanicemine

object_name: Depressed mood


subject: UNII:9TMU325RK3

object_name: Cancer patients and suicide and depression


subject: UNII:9TMU325RK3

object_name: Depressed - symptom


subject: UNII:9TMU325RK3

object_name: Depression, CTCAE


subject: CHEBI:60799

subject_name: Esketamine

object_name: Post-thoracotomy pain syndrome


subject: CHEBI:60799

object_name: Thoracic Diseases


subject: UMLS:C0528521

subject_name: Strogen

object_name: female infertility


subject: UMLS:C2347328

subject_name: sirolimus protein-bound particles

object_name: Perivascular epithelioid tumor, malignant


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: small cell lung carcinoma


subject: CHEBI:31596

subject_name: Febuxostat

object_name: ulcerative colitis


subject: CHEBI:31596

object_name: inflammatory bowel disease 1


subject: UNII:2Z03364G96

subject_name: Dapansutrile

object_name: Schnitzler syndrome


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: ovarian cancer


subject: UMLS:C4727210

object_name: ovarian neoplasm


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: diabetic ketoacidosis


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2

object_name: carotid disease


subject: PUBCHEM.COMPOUND:4056

object_name: arteriosclerosis disorder


subject: PUBCHEM.COMPOUND:4056

object_name: atherosclerosis


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: UNII:71ANL51TLA


subject: UNII:71ANL51TLA


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: CHEBI:28869


subject: CHEBI:28869


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: UNII:12V8PA4WCH


subject: UNII:12V8PA4WCH


subject: CHEBI:16374

subject_name: Menatetrenone


subject: CHEBI:16374


subject: CHEBI:16374


subject: UNII:2WTV10SIKH

subject_name: Mitapivat

object_name: hemolytic anemia


subject: UMLS:C0762110

object_name: end stage renal failure


subject: UMLS:C0762110

object_name: Chronic uremia


subject: CHEBI:231425

subject_name: tolvaptan


subject: CHEBI:231425


subject: CHEBI:229469

subject_name: Sulodexide

object_name: Varicose veins of lower extremity


subject: CHEBI:229469

object_name: Venous insufficiency of leg


subject: CHEBI:229469

object_name: peripheral vascular disease


subject: CHEBI:33353

subject_name: technetium atom

object_name: Kaposi Sarcoma


subject: CHEBI:33353

object_name: HIV infection


subject: UMLS:C4687517

object_name: osteogenesis imperfecta


subject: CHEBI:23359

subject_name: colchicine

object_name: aortic valve disease 2


subject: CHEBI:23359

object_name: aortic stenosis


subject: CHEBI:23359

object_name: aortic valve disease 3


subject: CHEBI:23359

object_name: Stenosis of aorta


subject: CHEBI:23359

object_name: aortic valve disorder


subject: CHEBI:23359

object_name: aortic valve disease 1


subject: CHEBI:23359

object_name: Aortic Valve Disease, CTCAE


subject: CHEBI:23359

object_name: aortic valve calcification


subject: CHEBI:23359

object_name: Calcification


subject: CHEBI:23359

object_name: calcinosis


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: food allergy


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: DRUGBANK:DB16912

subject_name: Zorevunersen

object_name: Dravet syndrome


subject: DRUGBANK:DB16912

object_name: developmental and epileptic encephalopathy, 6A


subject: CHEBI:167672

subject_name: Tovorafenib

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:167672

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:167672

object_name: High grade glioma


subject: CHEBI:167672

object_name: malignant glioma


subject: CHEBI:167672

object_name: WHO Grade 4 Glioma


subject: CHEBI:167672

object_name: grade III glioma


subject: CHEBI:167672

object_name: metastatic malignant neoplasm in the brain


subject: UNII:997WVV895X

subject_name: Rimegepant

object_name: Migraine with or without aura


subject: PUBCHEM.COMPOUND:15950844

object_name: neuralgia


subject: PUBCHEM.COMPOUND:15950844

object_name: Neuropathic pain


subject: PUBCHEM.COMPOUND:15950844

object_name: postherpetic neuralgia


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:85994

object_name: breast carcinoma


subject: CHEBI:85994

object_name: breast cancer


subject: UNII:843G0TDV51

object_name: Solid Neoplasm


subject: MESH:D010919

subject_name: Placebos

object_name: dyspepsia


subject: MESH:D010919

object_name: Dyspepsia, CTCAE


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Nasopharyngeal Carcinoma by AJCC v8 Stage


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: PUBCHEM.COMPOUND:46883775

object_name: toothache


subject: UMLS:C0771900

subject_name: aescin in horse chestnut

object_name: Anorectal Diseases


subject: UNII:1IJV77EI07

subject_name: Tepotinib

object_name: Gastroesophageal junction cancer


subject: UNII:1IJV77EI07

object_name: Stomach cancer


subject: UNII:1IJV77EI07

object_name: gastric cancer


subject: CHEBI:50733

subject_name: nutraceutical

object_name: osteoarthritis


subject: UNII:MG7D3QD743

subject_name: Atiprimod

object_name: plasma cell myeloma


subject: CHEBI:173081

subject_name: copanlisib dihydrochloride

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:173081

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: CHEBI:173081

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: CHEBI:173081

object_name: Diffuse large B-cell lymphoma recurrent


subject: UMLS:C4528197

subject_name: Copanlisib dihydrochloride


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C1446573

subject_name: Honeysuckle antigen

object_name: complication


subject: UMLS:C1446573

object_name: obstructive sleep apnea syndrome


subject: UMLS:C1613453

subject_name: HONEYSUCKLE substance


subject: UMLS:C1613453


subject: CHEBI:132268

subject_name: Dacomitinib

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: CHEBI:132268

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C4305974

subject_name: Recombinant human alpha 1-antitrypsin (raat)

object_name: alpha 1-antitrypsin deficiency


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Supratentorial Glioblastoma


subject: UMLS:C5201249

subject_name: CXCR4 INHIBITOR X4P-001

object_name: melanoma


subject: MESH:C514579

object_name: glioblastoma


subject: MESH:C514579

object_name: Brain Stem Glioblastoma


subject: MESH:C514579

object_name: glioma susceptibility 1


subject: MESH:C514579

object_name: Grade III Childhood Astrocytoma


subject: MESH:C514579

object_name: Adult Anaplastic Astrocytoma


subject: MESH:C514579

object_name: anaplastic astrocytoma


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C0003442

object_name: B-cell neoplasm


subject: UMLS:C0003442

object_name: T-Cell Lymphoma


subject: UMLS:C0003442

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C0003442

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C0003442

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396

object_name: bone marrow neoplasm


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:167450

object_name: chronic myelomonocytic leukemia


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:149509

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:149509

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:149509

object_name: morbid obesity


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:3347


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Hodgkin Disease


subject: CHEBI:7986


subject: CHEBI:7986


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: Enterobacteriaceae Infections


subject: CHEBI:90001

object_name: Invasive fungal infection


subject: CHEBI:90001

object_name: inflammatory disease


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: DRUGBANK:DB16615

subject_name: Krill oil

object_name: age-related macular degeneration


subject: UMLS:C3537046

subject_name: Norepinephrine Reuptake Inhibitor [EPC]

object_name: major depressive disorder


subject: UMLS:C3537213

subject_name: Serotonin and Norepinephrine Reuptake Inhibitor [EPC]


subject: CHEBI:30956

subject_name: trichloroacetic acid


subject: UMLS:C3536819

subject_name: Tricyclic Antidepressant [EPC]


subject: UMLS:C2348173

subject_name: GTx 024

object_name: Muscle Atrophy


subject: UMLS:C2348173

object_name: non-small cell lung carcinoma


subject: UMLS:C2933414

object_name: colorectal cancer


subject: UMLS:C2933414

object_name: colorectal carcinoma


subject: UMLS:C2933414

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:RZ22DI43TP

subject_name: PROTHROMBIN COMPLEX CONCENTRATE

object_name: liver disorder


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: UMLS:C4048712

subject_name: factor IX complex


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: intracerebral hemorrhage


subject: UNII:37KZM6S21G

object_name: Consciousness Disorders


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: GTOPDB:8270

subject_name: cenersen

object_name: acute myeloid leukemia


subject: UNII:K6KJ8AZ05F

subject_name: CENERSEN


subject: UMLS:C5691234

object_name: type 2 diabetes mellitus


subject: CHEBI:52763


subject: UMLS:C5432248

subject_name: Anti-SARS-CoV-2 IgY


subject: UMLS:C1957295

object_name: focal epilepsy


subject: UNII:6PJC3KPK6S

object_name: neoplasm


subject: UMLS:C1541384

subject_name: TLR7 Agonist 852A


subject: UNII:JH1CX8SG5V

subject_name: ORISMILAST

object_name: Acne inversa


subject: DRUGBANK:DB19042

subject_name: Orismilast


subject: PUBCHEM.COMPOUND:3685

object_name: Secondary Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:3685

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:3685

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:3685

object_name: Adult Acute Promyelocytic Leukemia


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:45716

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:45716

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:45716


subject: CHEBI:60791

subject_name: Xylocard

object_name: anxiety


subject: CHEBI:60791

object_name: anxiety disorder


subject: CHEBI:60791

object_name: Anxiety symptoms


subject: CHEBI:60791

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:60791

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol


subject: PUBCHEM.COMPOUND:6912


subject: PUBCHEM.COMPOUND:6912


subject: PUBCHEM.COMPOUND:6912


subject: PUBCHEM.COMPOUND:6912


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: Severely increased total eosinophil count


subject: UNII:71492GE1FX

object_name: hematologic disorder


subject: UNII:71492GE1FX

object_name: leukocyte disorder


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Odontogenic infection of jaw


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: cerebral malaria


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: medullary thyroid gland carcinoma


subject: CHEBI:60787

subject_name: TIMOLOL

object_name: Wound, non-healed


subject: CHEBI:39465

subject_name: timolol


subject: UNII:3YH0N35CE3

object_name: ulcerative colitis


subject: UNII:3YH0N35CE3

object_name: inflammatory bowel disease 1


subject: CHEMBL.COMPOUND:CHEMBL3545101


subject: CHEMBL.COMPOUND:CHEMBL3545101


subject: UNII:7UWT6B0L2U

subject_name: ETOKIMAB

object_name: chronic rhinosinusitis


subject: UMLS:C5238218

subject_name: Etokimab


subject: UMLS:C1611320


subject: UMLS:C0207975

subject_name: Kremezin

object_name: Loss of solute clearance


subject: MESH:C426645

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:55379

subject_name: camphorsulfonic acid

object_name: juvenile dermatomyositis


subject: CHEBI:4031

subject_name: Cyclosporine


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: CHEBI:44185

subject_name: Methotrexate


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: CHEMBL.COMPOUND:CHEMBL4594594

subject_name: ITEPEKIMAB

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5421034

subject_name: itepekimab


subject: CHEBI:142437

subject_name: lepirudin

object_name: heparin-induced thrombocytopenia


subject: UMLS:C0919146

subject_name: INJECTION, LEPIRUDIN, 50 MG Administered


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: ovarian carcinoma


subject: UNII:TWF0ML1CK8

object_name: peritoneum cancer


subject: UNII:TWF0ML1CK8

object_name: fallopian tube carcinoma


subject: UNII:TWF0ML1CK8

object_name: fallopian tube cancer


subject: CHEMBL.COMPOUND:CHEMBL1743006

subject_name: DALOTUZUMAB

object_name: rectal neoplasm


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Dental implant failure NOS


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C0018284

subject_name: Growth Factor


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Locally advanced breast cancer


subject: CHEBI:233362

object_name: malignant neoplasm of breast stage I


subject: CHEBI:233362

object_name: Carcinoma breast stage I


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: CHEBI:230905


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: estrogen-receptor positive breast cancer


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C2974509

object_name: hepatitis C


subject: MESH:C568346

subject_name: ClinOleic

object_name: malnutrition


subject: MESH:C568346

object_name: Obstruction


subject: MESH:C568346

object_name: Surgical procedure finding


subject: MESH:C568346

object_name: cancer


subject: MESH:C568346

object_name: neoplasm


subject: MESH:C568346

object_name: ileus


subject: MESH:C568346

object_name: Ileus, CTCAE


subject: CHEBI:33375

subject_name: Gadolinium

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:33375

object_name: acute myeloid leukemia


subject: CHEBI:33375

object_name: Childhood Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:33375

object_name: acute promyelocytic leukemia


subject: CHEBI:33375

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:175901

object_name: Ovarian cancer stage IV


subject: CHEBI:175901

object_name: Ovarian cancer stage III


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: peritoneum cancer


subject: CHEBI:64153

object_name: Recurrent ovarian cancer


subject: CHEBI:64153


subject: CHEBI:64153


subject: CHEBI:64153


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON

object_name: Type 1 diabetes mellitus with hypoglycemia


subject: CHEBI:5391

subject_name: Glucagon


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: osteomalacia


subject: CHEBI:90001

object_name: abnormal mineralization disorder


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: CHEBI:53394

subject_name: phosphotungstic acid macromolecule

object_name: Rest limb pain


subject: CHEBI:53394

object_name: peripheral vascular disease


subject: CHEBI:53394

object_name: peripheral arterial disease


subject: CHEBI:61432

subject_name: phosphotungstic acid polymer


subject: CHEBI:61432


subject: CHEBI:61432


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: fissured tongue


subject: UMLS:C3540708

object_name: geographic tongue


subject: UMLS:C3540708

object_name: Erythema migrans


subject: UMLS:C3540708

object_name: Lyme disease


subject: UMLS:C3540708

object_name: Infection in the elderly


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: CHEBI:47458

subject_name: Saracatinib

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:47458

object_name: stage IV pancreatic cancer


subject: CHEBI:47458

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:47458

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:47458

object_name: pancreatic adenocarcinoma


subject: UMLS:C5667069

subject_name: RET Inhibitor HS-10365

object_name: Childhood Solid Neoplasm


subject: UMLS:C5667069

object_name: Adult Solid Neoplasm


subject: UMLS:C5667069

object_name: Solid Neoplasm


subject: UMLS:C2347292

object_name: prostate carcinoma


subject: UMLS:C2347292

object_name: prostate cancer


subject: UMLS:C0062527

subject_name: Engerix-B

object_name: celiac disease


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Advanced gastric carcinoma


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:58097

object_name: orthostatic hypotension


subject: CHEBI:58097

object_name: Irritable heart


subject: CHEBI:58097

object_name: neurocirculatory asthenia


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:91899

object_name: Esophageal stricture


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: porphyria cutanea tarda


subject: CHEBI:5801

object_name: familial porphyria cutanea tarda


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4727210

object_name: clear cell renal carcinoma


subject: UMLS:C4727210

object_name: renal cell adenocarcinoma


subject: UMLS:C4727210

object_name: renal cell carcinoma


subject: UMLS:C0962969

subject_name: RAD 001

object_name: neuroendocrine neoplasm


subject: UMLS:C0962969

object_name: APUdoma


subject: UMLS:C0962969

object_name: pancreatic neuroendocrine tumor


subject: UMLS:C0962969

object_name: Neuroendocrine tumor of pancreas


subject: UMLS:C0962969

object_name: carcinoid tumor


subject: UMLS:C0962969

object_name: digestive system neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:50381

subject_name: Miglustat

object_name: hereditary spastic paraplegia


subject: CHEBI:177770

subject_name: Ganetespib

object_name: triple-negative breast carcinoma


subject: CHEBI:177770

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:TC549UFL8P

object_name: asthma


subject: UMLS:C1831848


subject: CHEBI:4975

subject_name: Famotidine

object_name: Marginal ulcer


subject: CHEBI:7772

subject_name: omeprazole


subject: UMLS:C3177639

object_name: septic shock


subject: MESH:D012982

subject_name: Sodium, Dietary

object_name: hypertension


subject: MESH:D012982

object_name: Hypertension, CTCAE


subject: MESH:D012982

object_name: obstructive sleep apnea syndrome


subject: CHEBI:73461

subject_name: Cys-Pro

object_name: psoriasis


subject: CHEBI:30663

subject_name: cyclopentadienyl group


subject: CHEBI:17698

subject_name: Chloramphenicol


subject: CHEBI:16486

subject_name: cyclopentanone


subject: CHEBI:3380

subject_name: Captopril


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: sickle cell disease


subject: CHEBI:29708

subject_name: Zinc gluconate

object_name: HIV infection


subject: CHEBI:29708

object_name: Inflammation


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: CHEBI:33198


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: PUBCHEM.COMPOUND:23664049


subject: MESH:D019275

subject_name: Radiopharmaceuticals

object_name: Alzheimer disease type 1


subject: MESH:D019275

object_name: Alzheimer disease


subject: MESH:D019275

object_name: mild neurocognitive disorder


subject: MESH:D019275

object_name: mild cognitive impairment


subject: MESH:D019275

object_name: progressive supranuclear palsy


subject: CHEBI:8382

subject_name: Prednisone

object_name: ulcerative colitis


subject: CHEBI:8382

object_name: inflammatory bowel disease 1


subject: CHEBI:124914

subject_name: Voxtalisib

object_name: cancer


subject: CHEBI:124914

object_name: neoplasm


subject: CHEBI:124914

object_name: non-small cell lung carcinoma


subject: CHEBI:71958


subject: CHEBI:71958


subject: CHEBI:71958


subject: DRUGBANK:DB05241


subject: DRUGBANK:DB05241


subject: DRUGBANK:DB05241


subject: UMLS:C3642376


subject: UMLS:C3642376


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: intracranial arteriosclerosis


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:3745

subject_name: clindamycin

object_name: Chapped lip


subject: CHEBI:8347

subject_name: Povidone-iodine

object_name: staphylococcus aureus infection


subject: CHEBI:77260

subject_name: Omeprazole

object_name: preeclampsia


subject: CHEBI:6801

subject_name: Metformin


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: Renal Function


subject: CHEBI:3423

subject_name: Carmustine

object_name: Adult Gliosarcoma


subject: CHEBI:3423

object_name: gliosarcoma


subject: CHEBI:3423

object_name: Childhood Gliosarcoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:125354

subject_name: Plerixafor

object_name: glioblastoma


subject: CHEBI:125354

object_name: Childhood Glioblastoma


subject: CHEBI:125354

object_name: adult glioblastoma


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:64312

subject_name: Memantine

object_name: Kinetic tremor


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: alopecia areata


subject: UNII:420K487FSG

object_name: alopecia


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: CHEBI:62880

subject_name: Veliparib

object_name: liver carcinoma


subject: UMLS:C1831920

subject_name: ABT 888


subject: UMLS:C1831920

object_name: Childhood Breast Carcinoma


subject: UMLS:C1831920

object_name: breast carcinoma


subject: UMLS:C1831920

object_name: breast cancer


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: primary peritoneal carcinoma


subject: UMLS:C0919079

object_name: Primary Peritoneal Cancer


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: Caffeine-related disorder


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:75998

subject_name: Trametinib

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:145499

subject_name: Donepezil

object_name: Memory Impairment, CTCAE 5.0


subject: CHEBI:47657

subject_name: Roflumilast

object_name: amnesia


subject: CHEBI:47657


subject: CHEBI:47657

object_name: Alzheimer disease


subject: CHEMBL.COMPOUND:CHEMBL1187846

subject_name: SCOPOLAMINE


subject: CHEMBL.COMPOUND:CHEMBL1187846


subject: CHEMBL.COMPOUND:CHEMBL1187846


subject: KEGG.COMPOUND:C01851

subject_name: Scopolamine


subject: KEGG.COMPOUND:C01851


subject: KEGG.COMPOUND:C01851


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine

object_name: Childhood Solid Neoplasm


subject: UNII:39IS23Q1EW

object_name: Adult Solid Neoplasm


subject: UNII:39IS23Q1EW

object_name: Solid Neoplasm


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE

object_name: myeloid neoplasm


subject: PUBCHEM.COMPOUND:5458171

object_name: acute leukemia of ambiguous lineage


subject: DRUGBANK:DB14322

subject_name: Coconut oil

object_name: multiple sclerosis


subject: CHEBI:73024

subject_name: O-acetylcarnitine


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: UMLS:C4741402

subject_name: Methyl B-12


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:15891

subject_name: Taurine


subject: CHEBI:16389

subject_name: Ubiquinone Q2


subject: PUBCHEM.COMPOUND:119058

subject_name: Ubiquinones


subject: CHEBI:46245

subject_name: Ubidecarenone


subject: CHEBI:16919

subject_name: Creatine


subject: PUBCHEM.COMPOUND:135483998


subject: PUBCHEM.COMPOUND:135402010


subject: CHEBI:15641

subject_name: 5-methyltetrahydrofolic acid


subject: CHEBI:57986


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:33283

subject_name: THIAMINE


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:31215

subject_name: anecortave

object_name: Disorder of intraocular pressure


subject: CHEBI:31215

object_name: Intraocular Pressure


subject: CHEBI:31215

object_name: Transplanted organ and tissue status


subject: CHEBI:31215

object_name: Transplant


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Locally Advanced Triple-Negative Breast Carcinoma


subject: CHEBI:231005

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: CHEBI:231005

object_name: Locally Advanced HER2-Negative Breast Carcinoma


subject: CHEBI:231005

object_name: Unresectable HER2-Negative Breast Carcinoma


subject: CHEBI:231005

object_name: Metastatic HER2-Negative Breast Carcinoma


subject: CHEBI:231005

object_name: Locally Advanced Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:231005

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:231005

object_name: Unresectable Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:231005

object_name: Metastatic Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: UNII:2LHZ9ZC3YO

subject_name: Tolinapant


subject: UNII:2LHZ9ZC3YO

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UNII:2LHZ9ZC3YO


subject: UNII:2LHZ9ZC3YO


subject: UNII:2LHZ9ZC3YO


subject: UNII:2LHZ9ZC3YO


subject: UNII:2LHZ9ZC3YO

object_name: invasive breast carcinoma


subject: UNII:2LHZ9ZC3YO


subject: UNII:2LHZ9ZC3YO

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:2LHZ9ZC3YO


subject: UNII:2LHZ9ZC3YO


subject: UNII:2LHZ9ZC3YO


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Sclerodactyly


subject: CHEBI:192614

object_name: diffuse scleroderma


subject: CHEBI:192614

object_name: Raynaud disease


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:229599

subject_name: Trofinetide

object_name: traumatic encephalopathy


subject: UMLS:C2715489


subject: CHEBI:177298

object_name: malignant glioma


subject: CHEBI:176844

subject_name: Niraparib


subject: UMLS:C4082706

subject_name: Temodal


subject: UNII:JM2621P2LS

subject_name: Synthetic Conjugated Estrogens, A

object_name: Menopause present (finding)


subject: UNII:JM2621P2LS

object_name: Menopause


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: hematologic disorder


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: inflammatory bowel disease


subject: DRUGBANK:DB14101

object_name: irritable bowel syndrome


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Mild Traumatic Brain Injury


subject: CHEBI:6541

subject_name: Losartan

object_name: urinary tract obstruction


subject: CHEBI:6541

object_name: Adverse reaction caused by losartan


subject: CHEBI:6541

object_name: urinary system disorder


subject: CHEBI:71023

subject_name: Alcaftadine

object_name: atopic conjunctivitis


subject: CHEBI:95341

subject_name: Baricitinib

object_name: nephritis


subject: CHEBI:95341

object_name: Lupus or SLE


subject: DRUGBANK:DB17511

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB17511

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB17511

object_name: Solid Neoplasm


subject: DRUGBANK:DB17511

object_name: head and neck squamous cell carcinoma


subject: DRUGBANK:DB17511

object_name: melanoma


subject: UNII:UVJ7NL8S2P

subject_name: Imlifidase

object_name: anti-glomerular basement membrane disease


subject: UNII:UVJ7NL8S2P


subject: UMLS:C4733424

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4733424

object_name: acute myeloid leukemia


subject: MESH:C000621664

subject_name: Naltrexone-Bupropion combination

object_name: obesity due to congenital leptin deficiency


subject: MESH:C000621664

object_name: obesity due to leptin receptor gene deficiency


subject: MESH:C000621664

object_name: morbid obesity


subject: MESH:C000621664

object_name: bariatric surgery candidate


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Infiltrating Cervical Carcinoma


subject: CHEBI:5001

object_name: cervical intraepithelial neoplasia


subject: CHEBI:5001

object_name: dysplasia of cervix


subject: UMLS:C2976005

object_name: hypertension


subject: UMLS:C2976005

object_name: Hypertension, CTCAE


subject: UMLS:C4287682

subject_name: c-Met Inhibitor HS-10241


subject: UMLS:C4287682

object_name: carcinoma


subject: MESH:C000711267

object_name: neuroendocrine neoplasm


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Oral mucosal disease due to graft-versus-host disease


subject: PR:000001890

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:578798

subject_name: Tridesilon

object_name: hyperpigmentation of the skin


subject: PUBCHEM.COMPOUND:578798

object_name: Hyperpigmentation, CTCAE


subject: CHEBI:204734

subject_name: Desonide


subject: CHEBI:204734


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: neovascular glaucoma


subject: UMLS:C0042210

subject_name: Vaccines

object_name: type 1 diabetes mellitus


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C2346611

subject_name: ARRY 520

object_name: plasma cell leukemia


subject: PR:000003045

subject_name: kinesin-like protein KIF11


subject: PR:000003045

object_name: plasma cell myeloma


subject: UMLS:C1999216

subject_name: Inhibitor


subject: UMLS:C1999216


subject: CHEBI:35341

subject_name: steroid


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: UMLS:C5782153


subject: GTOPDB:4934

subject_name: G-CSF


subject: UMLS:C4053637

object_name: Childhood Solid Neoplasm


subject: UMLS:C4053637

object_name: Adult Solid Neoplasm


subject: UMLS:C4053637

object_name: Solid Neoplasm


subject: CHEBI:29108

subject_name: Calcium cation

object_name: influenza


subject: CHEBI:22984

subject_name: Calcium


subject: MESH:D010919

subject_name: Placebos

object_name: diabetes mellitus


subject: CHEBI:231594

subject_name: Norgestrel

object_name: Complex Endometrial Hyperplasia with Atypia


subject: CHEBI:231594

object_name: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: UNII:MW2AIJ8USP

subject_name: Elubrixin

object_name: COPD, severe early onset


subject: UNII:MW2AIJ8USP

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:24956525

subject_name: Tyrosine kinase inhibitor

object_name: liver neoplasm


subject: UMLS:C1268567

subject_name: Protein-tyrosine kinase inhibitor


subject: CHEBI:15355

subject_name: Acetylcholine

object_name: Vasodilation disorder


subject: CHEBI:15355

object_name: Oral soft tissue conditions


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: anal canal squamous cell carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Anal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Anal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage I Anal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Anal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Anal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Anal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIA Anal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIB Anal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: cataract


subject: UniProtKB:P19726

object_name: Cataract, CTCAE 3.0


subject: UniProtKB:P19726

object_name: Cataract, CTCAE 5.0


subject: UniProtKB:P19726

object_name: cataract on exam (physical finding)


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Neuropathy caused by human immunodeficiency virus


subject: UMLS:C0678449

object_name: Pain Disorder


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UMLS:C4723538

subject_name: fremanezumab-vfrm

object_name: migraine


subject: UMLS:C4723538

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:6402

subject_name: Leflunomide

object_name: Plasma cell myeloma refractory


subject: CHEBI:6402

object_name: Plasma cell myeloma recurrent


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: tinea infection


subject: CHEBI:94705


subject: CHEBI:9448

subject_name: Terbinafine


subject: CHEBI:94366

subject_name: itraconazole


subject: UMLS:C5911031

subject_name: tocilizumab-aazg

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: UMLS:C5911031

object_name: Delayed cerebral ischaemia


subject: UMLS:C5911047

subject_name: Tyenne


subject: UMLS:C5911047


subject: PUBCHEM.COMPOUND:76322320

subject_name: COLISTIN

object_name: Acinetobacter infectious disease


subject: CHEBI:37943

subject_name: colistin


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:70752

subject_name: Dabigatran


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: renal carcinoma


subject: UMLS:C0003442

object_name: kidney neoplasm


subject: UMLS:C0003442

object_name: kidney cancer


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: adrenal cortex carcinoma


subject: UNII:9AG41L3AOQ

object_name: adenoid cystic carcinoma


subject: UMLS:C5446534

subject_name: Gimistotug

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5446534

object_name: non-small cell lung carcinoma


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:73024

object_name: amyotrophic lateral sclerosis


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: CHEBI:57589


subject: GTOPDB:7786

subject_name: pascolizumab

object_name: pulmonary tuberculosis


subject: UNII:N1IOA09R6A

subject_name: PASCOLIZUMAB


subject: UMLS:C2982101

subject_name: Pascolizumab


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: lupus nephritis


subject: CHEBI:58097

object_name: Blunt injury of thorax


subject: CHEBI:17303

subject_name: Morphine


subject: PR:000022848

subject_name: guanosine-inosine kinase

object_name: viral disease


subject: UniProtKB:P0AEW6

subject_name: INGK_ECOLI Guanosine-inosine kinase (sprot)


subject: CHEBI:52763

object_name: heart failure


subject: CHEBI:52763

object_name: Heart Failure, CTCAE


subject: UNII:09495UIM6V

subject_name: Bimekizumab

object_name: rheumatoid arthritis


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: optic neuritis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:90531

subject_name: Sotrastaurin

object_name: diffuse large B-cell lymphoma


subject: CHEBI:90531

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:90531

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C2830197


subject: UMLS:C2830197


subject: UMLS:C2830197


subject: CHEBI:53498

subject_name: triacetylcellulose

object_name: skin disorder


subject: UMLS:C2962221

subject_name: TAC


subject: CHEMBL.COMPOUND:CHEMBL2109569

subject_name: AUROGRAB

object_name: staphylococcal infection


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: thalassemia


subject: CHEBI:4356

object_name: Iron Overload


subject: CHEBI:4356

object_name: iron poisoning


subject: CHEBI:4356

object_name: Iron Overload, CTCAE


subject: UNII:GBZ5UC0RME

object_name: metabolic disease


subject: UNII:GBZ5UC0RME

object_name: Seizure Related to COVID-19


subject: UNII:GBZ5UC0RME

object_name: epilepsy


subject: UNII:GBZ5UC0RME

object_name: visual epilepsy


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: emphysema


subject: UMLS:C1541159

subject_name: CoFactor brand of 5,10-methylenetetrahydrofolate

object_name: metastatic colorectal cancer


subject: UMLS:C0178555

subject_name: chemical cofactor


subject: DRUGBANK:DB05308

object_name: rectal carcinoma


subject: DRUGBANK:DB05308

object_name: rectal cancer


subject: DRUGBANK:DB05308

object_name: Childhood Rectal Carcinoma


subject: DRUGBANK:DB05308


subject: DRUGBANK:DB05308

object_name: colon carcinoma


subject: DRUGBANK:DB05308

object_name: colorectal cancer


subject: DRUGBANK:DB05308

object_name: colon cancer


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: enterovirus infectious disease


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: PUBCHEM.COMPOUND:3005

subject_name: Dexamethasone palmitate

object_name: Postoperative Pain, Chronic


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Posterior blepharitis


subject: CHEBI:17650

object_name: dry eye syndrome


subject: CHEBI:17650

object_name: Dry Eye, CTCAE


subject: CHEBI:17650

object_name: Dryness of eye


subject: CHEBI:3423

subject_name: Carmustine

object_name: Childhood Brain Neoplasm


subject: CHEBI:3423

object_name: Childhood Solid Neoplasm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:85078

subject_name: Dapagliflozin


subject: CHEBI:85078


subject: CHEBI:63632

subject_name: Topotecan


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: Neonatal necrotizing enterocolitis


subject: DRUGBANK:DB19249

object_name: difficult; feeding, newborn


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: acute coronary syndrome


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: Mental deterioration


subject: CHEBI:28911

object_name: Cognitive impairment


subject: CHEBI:28911

object_name: osteoporosis


subject: CHEBI:28911

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:28911

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:28911

object_name: Osteoporosis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:27470


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:9139

subject_name: Sildenafil

object_name: non-arteritic anterior ischemic optic neuropathy


subject: CHEBI:95021

subject_name: pemetrexed

object_name: breast neoplasm


subject: CHEBI:63724


subject: UMLS:C4743101

object_name: Congenital IGHD


subject: UMLS:C4743101

object_name: Reduced circulating growth hormone concentration


subject: UNII:Z07JR07J6C

subject_name: Namodenoson

object_name: Cirrhosis


subject: UNII:Z07JR07J6C

object_name: liver cirrhosis


subject: UNII:Z07JR07J6C

object_name: liver carcinoma


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol

object_name: Metastatic malignant neoplasm to liver


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412

object_name: adult hepatocellular carcinoma


subject: UNII:CLH5FT6412

object_name: liver cancer


subject: UNII:CLH5FT6412

object_name: pediatric hepatocellular carcinoma


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412

object_name: Atrophy of liver


subject: UNII:CLH5FT6412

object_name: liver neoplasm


subject: UNII:CLH5FT6412

object_name: Adult Liver Carcinoma


subject: CHEBI:229906

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:22175537

subject_name: Lapaquistat acetate


subject: UMLS:C2825674

subject_name: Lapaquistat Acetate


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: alcoholic hepatitis


subject: CHEBI:100241

object_name: alcoholic liver cirrhosis


subject: UMLS:C5777100

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C5777100

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C5777100

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C4687395


subject: UMLS:C4687395


subject: UMLS:C4687395


subject: CHEBI:64816

object_name: hemophagocytic syndrome


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UMLS:C0699618

subject_name: Saizen

object_name: infertility


subject: UMLS:C3813201

subject_name: Oral Rehydration Solution OS-1

object_name: type 2 diabetes mellitus


subject: UMLS:C3813201

object_name: Insulin resistance


subject: UMLS:C3813201

object_name: Postoperative Complications


subject: UMLS:C0078516

subject_name: World Health Organization oral rehydration solution


subject: UMLS:C0078516


subject: UMLS:C0078516


subject: UMLS:C1443923

subject_name: Oral rehydration solution


subject: UMLS:C1443923


subject: UMLS:C1443923


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: electrocardiography


subject: UMLS:C3640220

object_name: non-small cell lung carcinoma


subject: CHEBI:136044

subject_name: Fimasartan

object_name: Critical stenosis of aortic valve


subject: CHEBI:50730

subject_name: Montelukast

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:177833

subject_name: Cilengitide

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:177833

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:177833

object_name: metastatic melanoma


subject: CHEBI:177833

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: PR:000023565

subject_name: DNA polymerase I

object_name: cardiovascular disorder


subject: UniProtKB:P00582

subject_name: DPO1_ECOLI DNA polymerase I (sprot)


subject: CHEBI:84040


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:30762

subject_name: salicylate

object_name: psoriasis


subject: CHEBI:9008

subject_name: salicylurate


subject: CHEBI:16914

subject_name: Salicylic acid


subject: PUBCHEM.COMPOUND:45375955

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:45375955

object_name: lymphoma


subject: PUBCHEM.COMPOUND:45375955

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:45375955

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:45375955

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:45375955

object_name: Neoplasm Metastasis


subject: CHEBI:8028

subject_name: Perphenazine

object_name: psychosis


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Acute anal fissure


subject: CHEBI:28787

object_name: Anal Pain, CTCAE


subject: CHEBI:28787

object_name: Anal pain


subject: CHEBI:28787

object_name: Anorectal Diseases


subject: UMLS:C0731141

subject_name: GTN


subject: UMLS:C0731141


subject: UMLS:C0731141


subject: UMLS:C0731141


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg

object_name: Carcinoma breast stage IV


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Pleural effusion


subject: CHEBI:474053

object_name: Pleural Effusion, CTCAE


subject: CHEBI:474053

object_name: x-ray of chest: pleural effusion


subject: CHEBI:474053

object_name: pleurisy


subject: CHEBI:474053

object_name: pleural empyema


subject: CHEBI:474053

object_name: empyema


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Nociceptive Pain


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802

object_name: opioid use


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: no feeling or sensation of skin


subject: CHEBI:26710

object_name: Sensory Loss


subject: CHEBI:26710


subject: CHEBI:26710


subject: UMLS:C4279276

object_name: rheumatoid arthritis


subject: UNII:01KC87F8FE

object_name: Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Nulliparous


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Arrhythmia


subject: CHEBI:15365

subject_name: Aspirin

object_name: ototoxicity


subject: CHEBI:15365

object_name: deafness


subject: CHEBI:15365

object_name: hearing loss by exam


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Non-metastatic prostate cancer


subject: UMLS:C4722508

subject_name: Polycap

object_name: stroke disorder


subject: UMLS:C4722508

object_name: cerebrovascular disorder


subject: UMLS:C4722508

object_name: Stroke (heart beat)


subject: UMLS:C4722508

object_name: Stroke, CTCAE


subject: UMLS:C4722508

object_name: Adherence To Medication Regime


subject: CHEBI:25036

subject_name: lignan

object_name: Childhood Breast Carcinoma


subject: CHEBI:25036

object_name: breast carcinoma


subject: CHEBI:25036

object_name: breast cancer


subject: CHEBI:25036

object_name: Malignant neoplasm of female breast


subject: CHEBI:25036

object_name: breast neoplasm


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones


subject: DRUGBANK:DB14101


subject: UNII:NR9ZYH80Z8


subject: UNII:NR9ZYH80Z8


subject: UNII:NR9ZYH80Z8


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: CHEBI:5000

subject_name: Fenfluramine

object_name: Continuous spike and waves during slow sleep


subject: CHEBI:5000

object_name: developmental and epileptic encephalopathy, 4


subject: CHEBI:5000

object_name: Drug Resistant Epilepsy


subject: CHEBI:25187

subject_name: Menthol

object_name: Prehypertension


subject: CHEBI:25187

object_name: hypertension


subject: CHEBI:25187

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: cervical cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: uterine cervix carcinoma in situ


subject: PUBCHEM.COMPOUND:14907381

object_name: Cervical intraepithelial neoplasia grade 2


subject: PUBCHEM.COMPOUND:14907381

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410

object_name: HIV infection


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: UNII:7RPW6SU9SC

object_name: Oral Mucositis


subject: UNII:7RPW6SU9SC

object_name: stomatitis


subject: UNII:7RPW6SU9SC

object_name: oral mucositis


subject: UNII:6ZA31Y954Z

subject_name: Brodalumab

object_name: psoriasis vulgaris


subject: MESH:D011054

subject_name: Poliovirus Vaccine, Inactivated

object_name: measles


subject: UMLS:C5241183

subject_name: Vaccine product containing only inactivated whole Human poliovirus antigen (medicinal product)


subject: UMLS:C0770740

subject_name: Insect Extract

object_name: sarcopenia


subject: CHEBI:17553


subject: CHEBI:71464

subject_name: Palmidrol


subject: UMLS:C1572795

subject_name: PEA Preparation


subject: CHEBI:18397

subject_name: Phenethylamine


subject: DRUGBANK:DB10551

subject_name: Pea


subject: UMLS:C5907936

subject_name: Anti-dectin-2 Agonist Monoclonal Antibody BDC-3042

object_name: Neck Carcinoma


subject: UMLS:C5907936

object_name: head and neck neoplasm


subject: UMLS:C5907936

object_name: head and neck cancer


subject: UMLS:C5907936

object_name: triple-negative breast carcinoma


subject: UMLS:C5907936

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5907936

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5907936

object_name: clear cell renal carcinoma


subject: UMLS:C5907936

object_name: non-small cell lung carcinoma


subject: UMLS:C5907936

object_name: colorectal cancer


subject: UMLS:C5907936

object_name: colorectal carcinoma


subject: UMLS:C5907936

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5907936

object_name: ovarian cancer


subject: UMLS:C5907936

object_name: ovarian neoplasm


subject: UMLS:C5907936

object_name: ovarian carcinoma


subject: UMLS:C5907936

object_name: melanoma


subject: UNII:6QVL057INT

subject_name: Cemiplimab


subject: UNII:6QVL057INT


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Klatskin Tumor


subject: CHEBI:114785

object_name: undifferentiated gallbladder carcinoma


subject: CHEBI:114785

object_name: gallbladder adenocarcinoma


subject: CHEBI:114785

object_name: adenocarcinoma of gallbladder with squamous metaplasia


subject: CHEBI:114785

object_name: extrahepatic bile duct adenocarcinoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Unresectable Gallbladder Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Cancer of Gallbladder


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:49956

subject_name: Xenon

object_name: General anaesthetic drug allergy


subject: CHEBI:90237

subject_name: Tandutinib

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:90237

object_name: clear cell renal carcinoma


subject: CHEBI:90237

object_name: Renal cell carcinoma recurrent


subject: CHEBI:90237

object_name: Renal cancer recurrent


subject: CHEBI:90237

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:90237

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:90237

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C1310928

object_name: psoriasis


subject: UNII:WDT28B7071

object_name: Blood Clot


subject: UNII:WDT28B7071

object_name: thrombosis


subject: UNII:WDT28B7071

object_name: Thrombosis of blood vessel


subject: CHEMBL.COMPOUND:CHEMBL4650381


subject: CHEMBL.COMPOUND:CHEMBL4650381


subject: CHEMBL.COMPOUND:CHEMBL4650381


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941


subject: CHEBI:37941


subject: CHEBI:63634

subject_name: Valdecoxib

object_name: osteoarthritis


subject: UMLS:C1705207

subject_name: Endostar

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C1705207

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C1705207

object_name: sarcoma


subject: UMLS:C1705207

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C1705207

object_name: soft tissue sarcoma


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON

object_name: Loss of hypoglycemic warning due to diabetes mellitus


subject: CHEBI:5391

subject_name: Glucagon


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Candidiasis of vagina


subject: UNII:L500PR95QA

object_name: vulvovaginal candidiasis


subject: UNII:L500PR95QA

object_name: Trichomonas vaginitis urogenital infection


subject: UNII:L500PR95QA

object_name: trichomonal vulvovaginitis


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6923

subject_name: Miconazole


subject: CHEBI:6923


subject: CHEBI:6923

object_name: bacterial vaginosis


subject: CHEBI:6923


subject: CHEBI:6923


subject: UNII:C9H2L21V7U

subject_name: SMOFlipid

object_name: cholestasis


subject: UNII:C9H2L21V7U

object_name: obstructive jaundice


subject: UMLS:C1616710

subject_name: Niravam

object_name: generalized anxiety disorder


subject: UMLS:C1616710

object_name: panic disorder


subject: UMLS:C1616710

object_name: panic disorder 1


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor


subject: CHEBI:50949


subject: CHEBI:50949


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: UMLS:C0360105


subject: UMLS:C0360105


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]


subject: UMLS:C2911696


subject: UMLS:C2911696


subject: UMLS:C1579361

subject_name: Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)


subject: UMLS:C1579361


subject: UMLS:C1579361


subject: UMLS:C3537046

subject_name: Norepinephrine Reuptake Inhibitor [EPC]


subject: UMLS:C3537046


subject: UMLS:C3537046


subject: UMLS:C3537213

subject_name: Serotonin and Norepinephrine Reuptake Inhibitor [EPC]


subject: UMLS:C3537213


subject: UMLS:C3537213